Investing.com - Takeda Pharma ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Takeda Pharma ADR announced earnings per share of $0.5838 on revenue of $8.66B. Analysts polled by Investing.com anticipated EPS of $0.3302 on revenue of $7.76B.
Takeda Pharma ADR shares are down 6.98% from the beginning of the year and are trading at $16.93 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR follows other major Healthcare sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar